By elucidating how C5a/C5aR1 signaling modulates PTEN and AKT activation, this study aims to clarify the molecular mechanisms linking complement activation to intracellular signaling pathways in LN and to provide experimental evidence to support the development of more targeted therapeutic approaches. The gene discussed is C5; the disease is lobular neoplasia.